Stock INKT MINK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts MiNK Therapeutics, Inc.

Equities

INKT

US6036931029

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
0.9642 USD -1.61% Intraday chart for MiNK Therapeutics, Inc. -0.59% -9.88%
May. 22 MiNK Therapeutics, Inc. Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting CI
May. 14 Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024
Transcript : MiNK Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Transcript : MiNK Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Transcript : MiNK Therapeutics, Inc., Q1 2023 Earnings Call, May 11, 2023
Transcript : MiNK Therapeutics, Inc., Q4 2022 Earnings Call, Mar 21, 2023
Transcript : MiNK Therapeutics, Inc. Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-18-2023 11:00 AM
Transcript : MiNK Therapeutics, Inc. - Special Call
Transcript : MiNK Therapeutics, Inc., Q3 2022 Earnings Call, Nov 03, 2022
Transcript : MiNK Therapeutics, Inc., Q2 2022 Earnings Call, Aug 09, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INKT Stock
  4. News MiNK Therapeutics, Inc.
  5. Transcripts